Whipple’s Disease: Our Own Experience and Review of the Literature
Author(s) -
Jan Bureš,
Marcela Kopáčová,
Tomáš Douda,
Jolana Bártová,
Jan Tomš,
Stanislav Rejchrt,
Ilja Tachecí
Publication year - 2013
Publication title -
gastroenterology research and practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 45
eISSN - 1687-630X
pISSN - 1687-6121
DOI - 10.1155/2013/478349
Subject(s) - medicine , whipple's disease , tropheryma whipplei , malabsorption , amoxicillin , doxycycline , gastroenterology , gentamicin , abdominal pain , antibiotics , penicillin , disease , surgery , microbiology and biotechnology , biology
Whipple's disease is a chronic infectious systemic disease caused by the bacterium Tropheryma whipplei . Nondeforming arthritis is frequently an initial complaint. Gastrointestinal and general symptoms include marked diarrhoea (with serious malabsorption), abdominal pain, prominent weight loss, and low-grade fever. Possible neurologic symptoms (up to 20%) might be associated with worse prognosis. Diagnosis is based on the clinical picture and small intestinal histology revealing foamy macrophages containing periodic-acid-Schiff- (PAS-) positive material. Long-term (up to one year) antibiotic therapy provides a favourable outcome in the vast majority of cases. This paper provides review of the literature and an analysis of our 5 patients recorded within a 20-year period at a tertiary gastroenterology centre. Patients were treated using i.v. penicillin G or amoxicillin-clavulanic acid + i.v. gentamicin for two weeks, followed by p.o. doxycycline (100 mg per day) plus p.o. salazopyrine (3 g per day) for 1 year. Full remission was achieved in all our patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom